Related Experiment Videos
Effect of phencyclidine on hepatic drug metabolism in the rat
Toxicology and Applied Pharmacology
|January 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Characterization of the highly variable bioavailability of tiludronate in normal volunteers using population pharmacokinetic methodologies.
European journal of drug metabolism and pharmacokinetics·2000
An approach for widening the bioequivalence acceptance limits in the case of highly variable drugs.
Pharmaceutical research·1995
Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
The Journal of pharmacology and experimental therapeutics·1993
Identification of N-beta-L-aspartyl-L-phenylalanine as a normal constituent of human plasma and urine.
The Journal of nutrition·1989
The effects of chronic ingestion of spironolactone on serum thyrotropin and thyroid hormones in the male rat.
Toxicology and applied pharmacology·1989
Auriculasin induces LACTB expression to regulate colorectal cancer cell apoptosis, ferroptosis, invasion, and in vivo tumor growth.
Toxicology and applied pharmacology·2026
Pharmacological inhibition of MET impairs hepatic regeneration and recovery in a murine model of acetaminophen-induced liver injury.
Toxicology and applied pharmacology·2026
Juglone induces GSDME-mediated pyroptosis by targeting HSP90α ATPase domain to promote STAT3 degradation in glioblastoma multiforme.
Toxicology and applied pharmacology·2026
ATF3 inhibits retinal pigment epithelial cell injury by activating HSPA5:A mechanistic insight for diabetic retinopathy.
Toxicology and applied pharmacology·2026
10-gingerol potentiates paclitaxel efficacy in triple-negative breast cancer by remodeling gut microbiota and suppressing PI3K/AKT/mTOR signaling pathway.
Toxicology and applied pharmacology·2026
Development of an in vitro chemical hazard screening method using human iPSCs with and without metabolic activation and application to chlorinated paraffins.
Toxicology and applied pharmacology·2026